Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial
- PMID: 24152889
- DOI: 10.1515/jpm-2013-0153
Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial
Abstract
Objective: To compare the effects of oral ferrous bisglycinate 25 mg iron/day vs. ferrous sulfate 50 mg iron/day in the prevention of iron deficiency (ID) and iron deficiency anemia (IDA) in pregnant women.
Design: Randomized, double-blind, intention-to-treat study.
Setting: Antenatal care clinic.
Sample: 80 healthy ethnic Danish pregnant women.
Methods: Women were allocated to ferrous bisglycinate 25 mg elemental iron (Aminojern®) (n=40) or ferrous sulfate 50 mg elemental iron (n=40) from 15 to 19 weeks of gestation to delivery. Hematological status (hemoglobin, red blood cell indices) and iron status (plasma iron, plasma transferrin, plasma transferrin saturation, plasma ferritin) were measured at 15-19 weeks (baseline), 27-28 weeks and 36-37 weeks of gestation.
Main outcome measures: Occurrence of ID (ferritin <15 μg/L) and IDA (ferritin <12 μg/L and hemoglobin <110 g/L).
Results: At inclusion, there were no significant differences between the bisglycinate and sulfate group concerning hematological status and iron status. The frequencies of ID and IDA were low and not significantly different in the two iron groups. The frequency of gastrointestinal complaints was lower in the bisglycinate than in the sulfate group (P=0.001). Newborns weight was slightly higher in the bisglycinate vs. the sulfate group (3601±517 g vs. 3395±426 g, P=0.09).
Conclusions: In the prevention of ID and IDA, ferrous bisglycinate was not inferior to ferrous sulfate. Ferrous bisglycinate in a low dose of 25 mg iron/day appears to be adequate to prevent IDA in more than 95% of Danish women during pregnancy and postpartum.
Similar articles
-
Body iron and individual iron prophylaxis in pregnancy--should the iron dose be adjusted according to serum ferritin?Ann Hematol. 2006 Sep;85(9):567-73. doi: 10.1007/s00277-006-0141-1. Epub 2006 May 30. Ann Hematol. 2006. PMID: 16733739 Clinical Trial.
-
Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate.Biomed Pharmacother. 2012 Sep;66(6):414-8. doi: 10.1016/j.biopha.2012.06.003. Epub 2012 Jun 29. Biomed Pharmacother. 2012. PMID: 22795809 Clinical Trial.
-
Iron prophylaxis during pregnancy -- how much iron is needed? A randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women.Acta Obstet Gynecol Scand. 2005 Mar;84(3):238-47. doi: 10.1111/j.0001-6349.2005.00610.x. Acta Obstet Gynecol Scand. 2005. PMID: 15715531 Clinical Trial.
-
Prepartum anaemia: prevention and treatment.Ann Hematol. 2008 Dec;87(12):949-59. doi: 10.1007/s00277-008-0518-4. Epub 2008 Jul 19. Ann Hematol. 2008. PMID: 18641987 Review.
-
Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women.Biometals. 2010 Jun;23(3):411-7. doi: 10.1007/s10534-010-9335-z. Epub 2010 Apr 21. Biometals. 2010. PMID: 20407805 Review.
Cited by
-
Oral iron therapy: Current concepts and future prospects for improving efficacy and outcomes.Br J Haematol. 2024 Mar;204(3):759-773. doi: 10.1111/bjh.19268. Epub 2024 Jan 22. Br J Haematol. 2024. PMID: 38253961 Review.
-
The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials.Nutr Rev. 2023 Jul 10;81(8):904-920. doi: 10.1093/nutrit/nuac106. Nutr Rev. 2023. PMID: 36728680 Free PMC article.
-
Risk factors for iron deficiency and iron deficiency anemia in pregnant women from plateau region and their impact on pregnancy outcome.Am J Transl Res. 2022 Jun 15;14(6):4146-4153. eCollection 2022. Am J Transl Res. 2022. PMID: 35836856 Free PMC article.
-
Efficacy and Safety of Ferrous Bisglycinate and Folinic Acid in the Control of Iron Deficiency in Pregnant Women: A Randomized, Controlled Trial.Nutrients. 2022 Jan 20;14(3):452. doi: 10.3390/nu14030452. Nutrients. 2022. PMID: 35276810 Free PMC article. Clinical Trial.
-
Ferritin-guided iron supplementation in whole blood donors: optimal dosage, donor response, return and efficacy (FORTE)-a randomised controlled trial protocol.BMJ Open. 2022 Mar 9;12(3):e056316. doi: 10.1136/bmjopen-2021-056316. BMJ Open. 2022. PMID: 35264362 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical